Menu
Currency
GWAS Study

Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.

Wu X, Ye Y, Rosell R et al.

21483023 PubMed ID
GWAS Study Type
1062 Participants
53 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WX
Wu X
YY
Ye Y
RR
Rosell R
AC
Amos CI
SD
Stewart DJ
HM
Hildebrandt MA
RJ
Roth JA
MJ
Minna JD
GJ
Gu J
LJ
Lin J
BS
Buch SC
NT
Nukui T
RS
Ramirez Serrano JL
TM
Taron M
CA
Cassidy A
LC
Lu C
CJ
Chang JY
LS
Lippman SM
HW
Hong WK
SM
Spitz MR
RM
Romkes M
YP
Yang P
Chapter II

Abstract

Summary of the research findings

Interindividual variation in genetic background may influence the response to chemotherapy and overall survival for patients with advanced-stage non-small cell lung cancer (NSCLC).

327 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

1062
Total Participants
GWAS
Study Type
Yes
Replicated
735 European ancestry individuals
Replication Participants
European
Ancestry
Spain, U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.